Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Recursion Pharmaceuticals, Inc. (RXRX): A Bull Case Theory

We came across a bullish thesis on Recursion Pharmaceuticals, Inc. on r/stocks by  Antique-Reference585. In this article, we will summarize the bulls’ thesis on RXRX. Recursion Pharmaceuticals, Inc.'s share was trading at $4.67 as of January 16th.

[caption id="attachment_399058" align="aligncenter" width="750"] Wichy/Shutterstock.com[/caption]

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and...